Reaction
Body Height Below Normal reporting signals
As of the last recalculation, Body Height Below Normal appears in 642 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is ANAKINRA (PRR 1,178.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anakinra | 311 | 1,178.0 | 1,200.6 |
| Sulfasalazine | 315 | 255.3 | 256.3 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 136 | 238.7 | 240.1 |
| Adalimumab-Fkjp | 190 | 188.5 | 189.2 |
| Tocilizumab | 322 | 182.6 | 183.1 |
| Adalimumab-Aaty | 188 | 181.7 | 182.4 |
| Triamcinolone Acetonide | 136 | 180.8 | 181.6 |
| Naproxen Sodium Tablet, Coated | 66 | 176.0 | 176.9 |
| Naproxen Sodium, Coated Tablets | 66 | 176.0 | 176.9 |
| Naproxen Sodium 220Mg | 66 | 175.8 | 176.6 |
| Adalimumab-Adaz | 190 | 165.4 | 166.0 |
| Abatacept | 315 | 143.8 | 144.1 |
| Naproxen | 223 | 140.5 | 140.9 |
| Hydroxychloroquine | 187 | 114.2 | 114.5 |
| Human Immunoglobulin G | 59 | 102.0 | 102.3 |
| Naproxen Sodium | 253 | 94.1 | 94.3 |
| Hydroxychloroquine Sulfate | 179 | 87.9 | 88.1 |
| Infliximab | 301 | 83.3 | 83.4 |
| Methotrexate | 326 | 50.0 | 50.0 |
| Methotrexate Sodium | 343 | 48.0 | 48.0 |
| Etanercept | 322 | 34.0 | 34.0 |
| Adalimumab | 322 | 28.6 | 28.6 |
| Thiotepa | 8 | 27.5 | 27.5 |
| Ifosfamide | 13 | 20.0 | 20.0 |